Drug Profile
Isolichenan
Latest Information Update: 30 May 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antidementias; Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 25 Aug 1998 No-Development-Reported for Alzheimer's disease in Japan (Unknown route)
- 30 May 1996 New profile